聚普瑞锌诱导HSP70保护大鼠胃黏膜损伤

目的探讨聚普瑞锌诱导热休克蛋白70(heat shock protein 70,HSP70)减轻大鼠胃黏膜损伤的作用机制。方法无水乙醇灌胃致大鼠胃黏膜损伤后分别应用聚普瑞锌100 mg/kg、200 mg/kg灌胃及赋形剂灌胃,同时以空白组作对照,检测胃黏膜HSP70蛋白表达。同时检测各实验组大鼠胃黏膜IGF-1含量和SOD活性。结果聚普瑞锌100 mg/kg治疗组治疗3 d时HSP70表达的相对灰度值为278.3%±10.8%;聚普瑞锌200 mg/kg治疗组治疗3 d时HSP70表达的相对灰度值为471.1%±24.7%,与空白组和赋形剂组相比,差异均有统计学意义(P0.01)。各实验组大鼠胃黏膜IGF-1含量和SOD活性差异无统计学意义(P0.05)。结论聚普瑞锌能够诱导损伤后大鼠胃黏膜产生大量HSP70,发挥保护胃黏膜的作用。     

Polaprezinc protects human colon cells from oxidative injury induced by hydrogen peroxide: relevant to cytoprotective heat shock proteins

INTRODUCTION Polaprezinc [N-(3-aminopropionyl)-L-histidinato zinc], an antiulcer drug, is a chelate compound consisting of zinc ion, L-carnosine, dipeptide of β-alanine, and L-histidine and has an antioxidant effect and anti-H pylori activity[1-4]. It ha…     

Heat shock protein 70 is involved in polaprezinc driven cell protection against Helicobacter pylori-induced injury

Polaprezinc (PZ) plays a role in the protection of gastric mucosa and inhibiting Helicobacter pylori (H. pylori) growth in vitro. The objective of this study was to determine the protective effects of PZ on human gastric epithelial cells (GES-1) against H. pylori-induced damage, while also examining heat shock protein 70 (HSP70) as a potential underlying factor in this protection. Our findings revealed that PZ exerted bactericidal effects against H. pylori strains. We also observed that PZ mitigated the H. pylori-induced damage to GES-1 cells by increasing cell viability, reducing LDH release, and decreasing the secretion of pro-inflammatory factors such as MCP-1 and IL-6. Co-culturing PZ with GES-1 cells significantly up-regulated the GES-1 HSP70 expression in both a time and dose-dependent manner. Pre-incubating (for 12 h) or co-culturing (for 24 h) GES-1 cells with PZ reversed the down-regulation of HSP70 in GES-1 cells caused by H. pylori infection. However, when quercetin was used to inhibit the up-regulation of HSP70 in GES-1 cells, the protective effect of PZ on GES-1 cells was significantly reduced. Based on the results of this study, PZ exhibits a protective role on GES-1 cells against H. pylori injury, as well as a direct bactericidal effect on H. pylori. HSP70 is involved in the PZ-driven host cell protection against H. pylori injury. These findings provide insight into alternative strategies for H. pylori treatment.     

原子吸收分光光度法测定人血浆中聚普瑞锌的浓度

目的：建立人血浆中聚普瑞锌浓度的原子分光光度法测定方法。方法：采用原子吸收光谱仪,设定波长为213.9 nm,光谱通带为0.5 nm,灯电流为10 mA,火焰类型为空气-乙炔,乙炔流量为1.2 L/min进行分析检测。结果：标准锌溶液线性范围为0.05～2.00 mg/L,定量下限为0.05 mg/L,回收率为103.0%,日内精密度及日间精密度均符合要求。结论：本方法具有选择性强、灵敏度高、稳定性好的特点,适合聚普瑞锌颗粒的人体药代动力学研究。     

Early and presymptomatic detection of Wilson's disease at the mandatory 3-year-old medical health care examination in Hokkaido Prefecture with the use of a novel automated urinary ceruloplasmin assay

Wilson’s disease (WND) is an autosomal recessive disorder of copper (Cu) accumulation leading to liver and/or brain damage. Oral chelating agents and diet are effective in treating WND. However, once irreversible damage has occurred, the effect of treatment is diminished and the patient’s quality of life is compromised. For these reasons an effective method for screening has been needed for early detection of presymptomatic patients. We conducted an early and presymptomatic detection of WND using a novel automated assay of ceruloplasmin (Cp) concentration in urine and selected the mandatory medical health care examination for 3-year-old children in Hokkaido Prefecture (the largest administrative division in Japan) as a sampling point. We measured urinary Cp concentrations in 11,362 children using an immunological latex agglutination assay kit developed by us. Among these children we identified a positive case with markedly reduced urinary Cp concentration. Detailed medical examination provided no clinical manifestations to support the diagnosis of WND, although serum Cp and Cu levels were remarkably low in this case. Therefore, we analyzed the WND gene in order to confirm the diagnosis. Sequence analysis revealed that the case was compound heterozygous for the WND gene mutations 2871del.C and D1296N. According to the Ferenci scoring system for WND diagnosis, the case was established as a WND patient at the presymptomatic stage. Consequently, the patient has maintained a good quality of life under medical treatment with polaprezinc administration to date. Our investigation suggests that the screening system for WND using the automated urinary assay at the mandatory medical health care examination for 3-year-old children is a noninvasive and efficient method for the early and presymptomatic diagnosis of WND.